Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma
用于青光眼小梁网治疗的干细胞磁控和纵向可视化
基本信息
- 批准号:10439504
- 负责人:
- 金额:$ 7.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAnteriorApoptosisAreaBlindnessCASP3 geneCell Culture TechniquesCell SurvivalCellsCellularityDataDiseaseDyesEffectivenessEyeEye diseasesFamily suidaeGlaucomaGlossaryGoalsHistologicHomeostasisHumanHydrogen PeroxideImageIn SituInflammatoryLabelLocationMagnetic nanoparticlesMagnetismMesenchymal Stem CellsModelingMonitorMusMutateNanotechnologyOcular HypertensionOrgan Culture TechniquesPatientsPeptidesPhotosensitivityPhysiologic Intraocular PressurePrimary Open Angle GlaucomaPropertyRNAReporterResearchRiskRisk FactorsSpatial DistributionSpecificitySystemTechnologyTestingTimeTissuesTrabecular meshwork structureTransgenic MiceUltrasonographyVesicleVisualizationWorkanterior chambercellular imagingcomparative efficacycytokinedesignexperimental studyimaging platformimaging systemimprovedin vivoinduced pluripotent stem cellinnovationinstrumentinterestmyocilinnanoparticlenoveloutcome predictionphotoacoustic imagingpressureserial imagingstem cell deliverystem cell technologystem cell therapystem cellssuperparamagnetismvirtual
项目摘要
Project Summary/Abstract
Glaucoma is a major cause of blindness and current treatments are insufficient. A major risk factor for glaucoma,
and the only treatable risk factor, is elevated intraocular pressure (IOP). Current IOP-lowering therapies fail too
often, and thus there continues to be great interest in novel IOP control strategies. The trabecular meshwork
(TM), the key tissue determining IOP, has reduced cellularity in glaucoma, which has led a number of groups to
study stem cell-based therapies for the TM. An obstacle to such therapies is cell delivery: current approaches
have low cell delivery efficiency and specificity for the TM, and cannot deliver cells to all parts of the TM.
Here a novel technological solution for “steering” stem cells to the TM is proposed, which can be additionally
used to visualize stem cell delivery and to monitor stem cell apoptosis. This approach will be tested in several
models of ocular hypertension. The key technology is superparamagnetic and photosensitive nanoparticles.
Their superparamagnetic properties mean that cells which have taken up these nanoparticles can be rapidly
steered to the TM by a magnet placed at the limbus. Their photosensitivity means that cells can be visualized by
ultrasound/photoacoustic imaging in the living eye. The functionality of these nanoparticles will be further
enhanced by using a photosensitive marker of active caspase-3 to monitor stem cell apoptosis. Our overall
objective is to validate these technologies as a safe and effective approach for monitoring and steering of stem
cells to the TM, thereby restoring intraocular pressure (IOP) homeostasis in glaucoma patients.
Three specific aims towards this long-term goal are proposed, building on our significant preliminary data. In aim
1, a novel caspase-3-sensitive reporter for monitoring apoptosis will be synthesized and characterized, and
magnets for steering stem cells to the TM will be optimized. In aim 2, an instrument capable of imaging of labeled
stem cells in whole eyes, including longitudinal monitoring of stem cell distribution and apoptosis, will be
developed. In aim 3, stem cells will be delivered to the TM in two glaucoma models, and their ability to restore
IOP homeostasis will be evaluated. The ability of ultrasound/photoacoustic imaging to monitor stem cell delivery
to the TM and stem cell apoptosis will also be validated; and mesenchymal stem cells (MSCs) will be compared
to differentiated induced pluripotent stem cells (iPSC-TMs) for their efficacy in restoring IOP homeostasis. This
project is highly innovative: it the first study to steer and visualize stem cells as part of a treatment for ocular
hypertension. It is also the first to compare the efficacy of MSCs vs. iPSC-TMs for treating ocular hypertension.
We expect, as suggested by our strong preliminary data, to discover that stem cells can be efficiently and
selectively steered to the TM by a simple magnet placed at the limbus for as little as 15 minutes; and that it will
be possible to accurately monitor the location of stem cells in the eye and stem cell apoptosis over time. Further,
we expect that TM function will be improved by stem cells steered in this way, as tested in 2 glaucoma models.
项目摘要/摘要
青光眼是导致失明的主要原因,目前的治疗方法不足。青光眼的主要危险因素,
唯一可治疗的危险因素是眼压升高。目前的降眼压疗法也失败了
因此,人们对新的眼压控制策略仍然非常感兴趣。小梁网
(TM),决定眼压的关键组织,已经减少了青光眼的细胞密度,这导致了一些小组
研究以干细胞为基础的TM疗法。这种疗法的一个障碍是细胞输送:目前的方法
TM的细胞输送效率和特异性较低,并且不能将细胞输送到TM的所有部分。
这里提出了一种新的技术解决方案,将干细胞“引导”到TM,该方案可以另外
用于可视化干细胞输送和监测干细胞凋亡。这一方法将在几个方面进行测试
高眼压模型。关键技术是超顺磁性和光敏纳米颗粒。
它们的超顺磁性意味着摄取这些纳米颗粒的细胞可以迅速
通过放置在边缘的磁铁引导到TM。它们的光敏性意味着细胞可以通过
活眼的超声/光声成像。这些纳米粒子的功能将进一步
通过使用活性caspase-3的光敏标记物来监测干细胞凋亡而增强。我们的整体
目的是验证这些技术是安全和有效的监测和转向阀杆的方法
Tm,从而恢复青光眼患者的眼压(IOP)动态平衡。
在我们重要的初步数据的基础上,提出了实现这一长期目标的三个具体目标。在AIM
1,将合成并表征一种新型的caspase-3敏感的细胞凋亡监测报告,以及
引导干细胞进入TM的磁铁将得到优化。在目标2中,能够对标记物进行成像的仪器
全眼干细胞,包括对干细胞分布和凋亡的纵向监测,将是
发展起来的。在AIM 3中,干细胞将在两个青光眼模型中被输送到TM,并恢复它们的能力
将评估眼压动态平衡。超声/光声成像监测干细胞输送的能力
还将验证TM和干细胞的凋亡;并将比较间充质干细胞(MSCs)
目的探讨分化诱导多能干细胞(IPSC-TMS)恢复眼压稳态的效果。这
该项目极具创新性:它是将干细胞作为眼科治疗的一部分并将其可视化的第一项研究
高血压。这也是第一次比较骨髓间充质干细胞和IPSC-TMS治疗高眼压的疗效。
我们希望,正如我们强有力的初步数据所表明的那样,干细胞可以有效地和
通过在边缘放置一块简单的磁铁,选择性地转向TM,时间短至15分钟;它将
随着时间的推移,可以准确监测干细胞在眼睛中的位置和干细胞的凋亡。此外,
我们希望通过这种方式引导干细胞,TM的功能将得到改善,正如在2个青光眼模型中所测试的那样。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STANISLAV Y EMELIANOV其他文献
STANISLAV Y EMELIANOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STANISLAV Y EMELIANOV', 18)}}的其他基金
Image-guided cancer therapy using heat activatable CAR T cells
使用热激活 CAR T 细胞进行图像引导癌症治疗
- 批准号:
10701849 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Image-guided cancer therapy using heat activatable CAR T cells
使用热激活 CAR T 细胞进行图像引导癌症治疗
- 批准号:
10587560 - 财政年份:2022
- 资助金额:
$ 7.55万 - 项目类别:
Trimodal vitality imaging of neural progenitor cells in the spinal cord
脊髓神经祖细胞的三模态活力成像
- 批准号:
10221069 - 财政年份:2020
- 资助金额:
$ 7.55万 - 项目类别:
Trimodal vitality imaging of neural progenitor cells in the spinal cord
脊髓神经祖细胞的三模态活力成像
- 批准号:
10032744 - 财政年份:2020
- 资助金额:
$ 7.55万 - 项目类别:
Trimodal Vitality Imaging of Neural Progenitor Cells in the Spinal Cord
脊髓神经祖细胞的三模态活力成像
- 批准号:
10397429 - 财政年份:2020
- 资助金额:
$ 7.55万 - 项目类别:
Ultrasound-guided photoacoustic imaging and tracking of stem cells in the spinal cord
超声引导光声成像和脊髓干细胞追踪
- 批准号:
9978212 - 财政年份:2020
- 资助金额:
$ 7.55万 - 项目类别:
Trimodal Vitality Imaging of Neural Progenitor Cells in the Spinal Cord
脊髓神经祖细胞的三模态活力成像
- 批准号:
10611905 - 财政年份:2020
- 资助金额:
$ 7.55万 - 项目类别:
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma
用于青光眼小梁网治疗的干细胞磁控和纵向可视化
- 批准号:
10653277 - 财政年份:2019
- 资助金额:
$ 7.55万 - 项目类别:
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma
用于青光眼小梁网治疗的干细胞磁控和纵向可视化
- 批准号:
10459456 - 财政年份:2019
- 资助金额:
$ 7.55万 - 项目类别:
Magnetic Steering and Longitudinal Visualization of Stem Cells for Trabecular Meshwork Therapy in Glaucoma
用于青光眼小梁网治疗的干细胞磁控和纵向可视化
- 批准号:
10179400 - 财政年份:2019
- 资助金额:
$ 7.55万 - 项目类别:
相似海外基金
Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10556857 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Fear and anxiety circuit mechanisms in anterior hypothalamic nucleus
下丘脑前核的恐惧和焦虑环路机制
- 批准号:
10789153 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Elucidating signaling networks in Anterior Segment development, repair and diseases
阐明眼前节发育、修复和疾病中的信号网络
- 批准号:
10718122 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
The Intimate Interplay Between Keratoconus, Sex Hormones, and the Anterior Pituitary
圆锥角膜、性激素和垂体前叶之间的密切相互作用
- 批准号:
10746247 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Anterior Insula Projections for Alcohol Drinking/Anxiety Interactions in Female and Male Rats
雌性和雄性大鼠饮酒/焦虑相互作用的前岛叶预测
- 批准号:
10608759 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Impact of tissue resident memory T cells on the neuro-immunepathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
- 批准号:
10804810 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Investigation of the effect of anterior eye shape on myopia progression due to prolonged near work.
研究因长时间近距离工作而导致的前眼形状对近视进展的影响。
- 批准号:
23K09063 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation and characterization of anterior pituitary stem cells from human pluripotent stem cells
人多能干细胞垂体前叶干细胞的产生和表征
- 批准号:
23K08005 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
EASI-TOC: Endovascular Acute Stroke Intervention-Tandem OCclusion: atrial of acute cervical internal carotid artery stenting during endovascularthrombectomy for anterior circulation stroke
EASI-TOC:血管内急性卒中干预-串联闭塞:前循环卒中血管内血栓切除术期间急性颈内动脉心房支架置入术
- 批准号:
490056 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Operating Grants
Anterior cruciate ligament injury: towards a gendered environmental approach
前十字韧带损伤:走向性别环境方法
- 批准号:
485090 - 财政年份:2023
- 资助金额:
$ 7.55万 - 项目类别:
Operating Grants